NCT03557619 - A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

March 21, 2026

Study Completion Date

March 21, 2026

Conditions

Hematologic Malignancies

Interventions

DRUG

Venetoclax

tablet; oral

DRUG

ethinyl estradiol/levonorgestrel

tablet; oral

Trial Locations (4)

RECRUITING

Peter MacCallum Cancer Centre-East Melbourne /ID# 225247, East Melbourne

COMPLETED

Gabrail Cancer Center Research /ID# 207039, Canton

COMPLETED

Duplicate_Henry Ford Health System /ID# 209090, Detroit

COMPLETED

Dartmouth-Hitchcock Medical Center /ID# 169097, Lebanon